Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Oncol.

Sec. Neuro-Oncology and Neurosurgical Oncology

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1587745

Radiomic features from the peritumoral region can be associated with epilepsy status of glioblastoma patients

Provisionally accepted
  • 1Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany
  • 2Division of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Baden-Württemberg, Germany
  • 3Medical Faculty Heidelberg, University of Heidelberg, Heidelberg, Baden-Württemberg, Germany
  • 4Neurologische Klinik, UniversitätsKlinikum Heidelberg, Heidelberg, Baden-Württemberg, Germany
  • 5Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany
  • 6Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany
  • 7Department of Functional Neuroanatomy, Heidelberg University, Heidelberg, Germany
  • 8Department of Neuroradiology, Geneva University Hospitals, Geneva, Switzerland

The final, formatted version of the article will be published soon.

Purpose: Identifying radiomics features that help to predict whether glioblastoma patients are prone to developing epilepsy may contribute to an improvement of preventive treatment and a better understanding of the underlying pathophysiology.In this retrospective study, 3 Tesla MRI data of 451 pre-treatment glioblastoma patients (mean age: 61.2 years ±11.8; 268 male, 183 female) were analyzed.336 patients reported no epilepsy, while 115 patients were diagnosed with symptomatic epilepsy. A total of 1546 radiomics features were extracted from contrast-enhancing tumor, peritumoral regions and normal-appearing white matter as regions of interest using PyRadiomics. The dataset was initially split into a training (70%) and a validation (30%) cohort. The training cohort was used for feature selection with ElasticNet and modeloptimization. Various machine-learning models, including logistic regression (LR), were used to predict epilepsy status. The models' performances were evaluated with the validation cohort and the area under the curve of receiver operating characteristics (AUC) was used as a measure. For identifying relevant features, permutation feature importance was applied.The performance of LR using radiomics features from only a single ROI in the validation cohort were AUC=0.83 (95%-CI: 0.76-0.91) and AUC=0.77 (95% CI: 0.69-0.85) for peritumoral and white matter region respectively. Most important features in peritumoral regions were shape features, while for the white matter region higher-order features from FLAIR were most relevant.Radiomics features from peritumoral and normal-appearing white matter can be associated with epilepsy status at diagnosis suggesting an important role of these regions for the development of epilepsy in glioblastoma patients.

Keywords: Glioblastoma, Epilepsy, Radiomics, MRI, machine-learning

Received: 04 Mar 2025; Accepted: 28 Jul 2025.

Copyright: © 2025 Yun, Jende, Holz, Garhöfer, Wolf, Hohmann, Vollmuth, Bendszus, Schlemmer, Sahm, Heiland, Wick, Venkataramani and Kurz. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Yeong Chul Yun, Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.